Merck scraps Keytruda lung cancer trial adding Bristol Myers’ Yervoy. What about the Opdivo combo?news2020-11-10T16:15:27+00:00November 10th, 2020|Fierce Pharma|
Pfizer, BioNTech set for billions in yearly sales as fast COVID-19 vaccine launch looms: analystsnews2020-11-10T15:57:03+00:00November 10th, 2020|Fierce Pharma|
Game on: Pfizer, BioNTech prepare to put COVID-19 shot distribution plan to the test after interim readoutnews2020-11-10T14:46:46+00:00November 10th, 2020|Fierce Pharma|
Always clean your hands: FDA cites compounder for workers’ failure to change gloves after handling trashnews2020-11-10T13:21:35+00:00November 10th, 2020|Fierce Pharma|
Eli Lilly wins FDA’s emergency nod for COVID-19 antibody—but, thanks to mixed data, it’s limitednews2020-11-10T12:58:31+00:00November 10th, 2020|Fierce Pharma|
Aspira adds slate of female execs as it launches new ovarian cancer awareness pushnews2020-11-10T10:04:52+00:00November 10th, 2020|Fierce Pharma|
Ogilvy Health’s global CEO looks to help pharma reassess corporate branding amid pandemicnews2020-11-09T22:48:11+00:00November 9th, 2020|Fierce Pharma|
French CMO Fareva adds 4 facilities, more than 1,000 employees in Euro growth spurtnews2020-11-09T21:20:40+00:00November 9th, 2020|Fierce Pharma|
After Pfizer’s vaccine data, analysts say COVID-19 drugmakers face questions about long-term sales prospectsnews2020-11-09T16:09:33+00:00November 9th, 2020|Fierce Pharma|
FDA reputation takes another hit after scathing aducanumab advisory panel meetingnews2020-11-09T15:50:34+00:00November 9th, 2020|Fierce Pharma|
